Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications
Combination of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: Why, when and How? An Exploration of the Rationale and Clinical Scenarios for Combining These 2 Adjunctive Agents.
Journal: Endocrinology and metabolism clinics of North America
Published: July 29, 2026
Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial.
Journal: Diabetes, obesity & metabolism
Published: May 21, 2026
Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis.
Journal: Diabetes & metabolism
Published: August 29, 2024
Glucose ingestion does not lower testosterone concentrations in men on testosterone therapy.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: April 21, 2024
Diabetes surpasses obesity as a risk factor for low serum testosterone level.
Journal: Diabetology & metabolic syndrome
Published: February 21, 2024
More on Semaglutide in Early Type 1 Diabetes. Reply.
Journal: The New England journal of medicine
Published: January 17, 2024
Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon.
Journal: World journal of diabetes
Published: November 03, 2023
Semaglutide in Early Type 1 Diabetes.
Journal: The New England journal of medicine
Published: September 06, 2023
Vasoactive mediators of hypertension in obesity.
Journal: American journal of physiology. Endocrinology and metabolism
Published: September 06, 2023
Insulin Resistance and Glycated Hemoglobin in Obesity Are Associated With Preference for Sugar-Sweetened Yogurt: A Pilot Study.
Journal: Psychosomatic medicine
Published: February 17, 2023
Recognizing the True Value of Testosterone Therapy in Health Care.
Journal: Androgens: clinical research and therapeutics
Published: December 13, 2022
Hypogonadotropic Hypogonadism in Diabesity: Pathogenic Factors and Therapeutic Implications.
Journal: Androgens: clinical research and therapeutics
Published: November 18, 2022
Last Updated: 09/26/2026